Could this news be a knight in the shining armour for Glenmark Pharmaceuticals?
Could this news be a knight in the shining armour for Glenmark Pharmaceuticals?

Could this news be a knight in the shining armour for Glenmark Pharmaceuticals?

Karan Dsij Article rating: 3.5

The stock is down by about 25 per cent from its high of Rs 690, which was registered in July 2021 and has been one of the underperformers over the last one year. Can this news trigger a change in the course of the trend of the stock? Only time would tell as the market participants would like to track the financial performance of the stock.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR